PCA
GNMK

Providence Capital Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Providence Capital Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40
Closed -$1K – 356
2021
Q1 		$1K Buy
+40
New +$743 ﹤0.01% 274

Providence Capital Advisors's GNMK Position: Q2 2021 in Review

Providence Capital Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 40 shares — an estimated $1K sold.

Providence Capital Advisors first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Providence Capital Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Providence Capital Advisors sold 40 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1K.
  • Providence Capital Advisors first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Providence Capital Advisors's GenMark Diagnostics, Inc position peaked at $1K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Providence Capital Advisors's 13F filing for Q2 2021, filed 9 Aug 2021.